Skip to content

Bohai Pharmaceuticals Group, Inc.: 10-Q filed 2012-05-14

What Bohai Pharmaceuticals Group, Inc. reported in its quarterly report filed 2012-05-14 (fiscal Q3 2012): 39 published measures, 108 facts as tagged in accession 0001144204-12-028573.

This filing

Form
10-Q (quarterly report)
Filed
2012-05-14
Fiscal period
fiscal Q3 2012
Accession
0001144204-12-028573 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Bohai Pharmaceuticals Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-03-31140,420,427USD
At 2011-06-3080,114,919USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-03-3157,302,199USD
At 2011-06-3012,206,912USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-03-3183,118,228USD
At 2011-06-3067,908,007USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-03-3123,044,256USD
At 2011-06-3013,344,426USD
At 2011-03-3110,665,517USD
At 2010-06-3017,149,082USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-03-315,303,918USD91
2011-07-01 to 2012-03-316,664,200USD275
2011-01-01 to 2011-03-312,685,346USD90
2010-07-01 to 2011-03-3112,238,716USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-07-01 to 2012-03-3115,770,702USD275
2010-07-01 to 2011-03-319,016,541USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-07-01 to 2012-03-31509,118USD275
2010-07-01 to 2011-03-3114,619USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-07-01 to 2012-03-313,240,921USD275
2010-07-01 to 2011-03-31-1,668,927USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-07-01 to 2012-03-31-9,519,284USD275
2010-07-01 to 2011-03-31-14,307,391USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-03-3150,447,600USD
At 2011-06-3043,783,400USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-01-01 to 2012-03-3117,861,085shares91
2011-07-01 to 2012-03-3117,861,085shares275
2011-01-01 to 2011-03-3117,544,163shares90
2010-07-01 to 2011-03-3116,988,489shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-01-01 to 2012-03-3123,086,085shares91
2011-07-01 to 2012-03-3123,086,085shares275
2011-01-01 to 2011-03-3122,808,885shares90
2010-07-01 to 2011-03-3122,439,202shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-01-01 to 2012-03-310.3USD/shares91
2011-07-01 to 2012-03-310.37USD/shares275
2011-01-01 to 2011-03-310.15USD/shares90
2010-07-01 to 2011-03-310.72USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-01-01 to 2012-03-310.28USD/shares91
2011-07-01 to 2012-03-310.37USD/shares275
2011-01-01 to 2011-03-310.14USD/shares90
2010-07-01 to 2011-03-310.59USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-03-312,174,128USD91
2011-07-01 to 2012-03-316,288,779USD275
2011-01-01 to 2011-03-31897,458USD90
2010-07-01 to 2011-03-313,523,145USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-03-3111,757,905USD
At 2011-06-305,214,962USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-07-01 to 2012-03-3144,000USD275
2010-07-01 to 2011-03-31184,344USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-03-318,269,457USD91
2011-07-01 to 2012-03-3123,147,601USD275
2011-01-01 to 2011-03-314,093,901USD90
2010-07-01 to 2011-03-3115,382,151USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-03-3155,672,584USD
At 2011-06-3031,818,270USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-01-01 to 2012-03-311,120,273USD91
2011-07-01 to 2012-03-3110,694,346USD275
2011-01-01 to 2011-03-31554,428USD90
2010-07-01 to 2011-03-312,203,775USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-03-3140,325,157USD
At 2011-06-309,328,515USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-03-312,913,463USD
At 2011-06-301,291,907USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2012-03-314,649,283USD
At 2011-06-300USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-03-3127,733,858USD
At 2011-06-3015,891,642USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-03-313,664,864USD
At 2011-06-301,511,021USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-03-3128,057,085USD91
2011-07-01 to 2012-03-3177,895,710USD275
2011-01-01 to 2011-03-3116,939,863USD90
2010-07-01 to 2011-03-3147,948,132USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-01-01 to 2012-03-3119,787,628USD91
2011-07-01 to 2012-03-3154,748,109USD275
2011-01-01 to 2011-03-3112,845,962USD90
2010-07-01 to 2011-03-3132,565,981USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-03-3117,861,085shares
At 2011-06-3017,861,085shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-03-315,835,597USD
At 2011-06-303,559,355USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-03-317,024,717USD
At 2011-06-304,312,333USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-03-31900,783USD
At 2011-06-301,060,138USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-03-317,478,046USD91
2011-07-01 to 2012-03-3112,952,979USD275
2011-01-01 to 2011-03-313,582,804USD90
2010-07-01 to 2011-03-3115,761,861USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-01-01 to 2012-03-315,924,580USD91
2011-07-01 to 2012-03-318,940,442USD275
2011-01-01 to 2011-03-313,085,570USD90
2010-07-01 to 2011-03-3114,299,744USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-2,163USD91
2011-07-01 to 2012-03-31-10,205USD275
2011-01-01 to 2011-03-31-546USD90
2010-07-01 to 2011-03-31-2,468USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-791,411USD91
2011-07-01 to 2012-03-31-10,194,622USD275
2011-01-01 to 2011-03-31-511,097USD90
2010-07-01 to 2011-03-31379,710USD274

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2011-07-01 to 2012-03-31700,734USD275
2010-07-01 to 2011-03-310USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-07-01 to 2012-03-310USD275
2010-07-01 to 2011-03-311,870,955USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-07-01 to 2012-03-314,421,640USD275
2010-07-01 to 2011-03-313,946,124USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-07-01 to 2012-03-31771,500USD275
2010-07-01 to 2011-03-311,201,923USD274

Inspect the source

Entity
Bohai Pharmaceuticals Group, Inc. / CIK 0001443242
Captured
SEC response SHA-256
231cd66af3d2b49ce2aa3d470fecf13855af56710429934b8f03d791fb54b2d8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001443242.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))